

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.23090290 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.67247703 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.55568427 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.38128066 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.34989378 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.15061195 |
| 7 | vocalization behavior (GO:0071625) | 4.09755155 |
| 8 | nucleobase catabolic process (GO:0046113) | 4.08650436 |
| 9 | glutamate secretion (GO:0014047) | 4.05756481 |
| 10 | locomotory exploration behavior (GO:0035641) | 3.99817862 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.93821443 |
| 12 | protein localization to synapse (GO:0035418) | 3.88928913 |
| 13 | neuronal action potential propagation (GO:0019227) | 3.88796201 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 3.78257246 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 3.74639634 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.69738614 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.66526142 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.53402370 |
| 19 | neurotransmitter secretion (GO:0007269) | 3.51008015 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.46961771 |
| 21 | exploration behavior (GO:0035640) | 3.35079398 |
| 22 | COPI coating of Golgi vesicle (GO:0048205) | 3.30976535 |
| 23 | Golgi transport vesicle coating (GO:0048200) | 3.30976535 |
| 24 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.24864519 |
| 25 | activation of protein kinase A activity (GO:0034199) | 3.24403019 |
| 26 | detection of calcium ion (GO:0005513) | 3.24186505 |
| 27 | neuron recognition (GO:0008038) | 3.23164665 |
| 28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.22179705 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.21337788 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 3.18115223 |
| 31 | innervation (GO:0060384) | 3.17833234 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.17621370 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.15631789 |
| 34 | synaptic transmission, glutamatergic (GO:0035249) | 3.11940846 |
| 35 | vesicle transport along microtubule (GO:0047496) | 3.07141183 |
| 36 | proline transport (GO:0015824) | 3.05195842 |
| 37 | regulation of axon guidance (GO:1902667) | 3.05130371 |
| 38 | axonal fasciculation (GO:0007413) | 3.04242448 |
| 39 | glutamate receptor signaling pathway (GO:0007215) | 3.01581484 |
| 40 | long-term synaptic potentiation (GO:0060291) | 2.97925881 |
| 41 | regulation of vesicle fusion (GO:0031338) | 2.97836041 |
| 42 | axon extension (GO:0048675) | 2.97168805 |
| 43 | layer formation in cerebral cortex (GO:0021819) | 2.95408185 |
| 44 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.94522737 |
| 45 | postsynaptic membrane organization (GO:0001941) | 2.93960866 |
| 46 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.91068700 |
| 47 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.82704480 |
| 48 | positive regulation of vesicle fusion (GO:0031340) | 2.82401789 |
| 49 | regulation of neurotransmitter secretion (GO:0046928) | 2.81760086 |
| 50 | dendritic spine morphogenesis (GO:0060997) | 2.81117430 |
| 51 | presynaptic membrane assembly (GO:0097105) | 2.80848309 |
| 52 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.80833579 |
| 53 | positive regulation of synapse maturation (GO:0090129) | 2.80696674 |
| 54 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.79867968 |
| 55 | negative regulation of axon guidance (GO:1902668) | 2.78356985 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.78088690 |
| 57 | membrane depolarization during action potential (GO:0086010) | 2.77639089 |
| 58 | neurotransmitter transport (GO:0006836) | 2.77538386 |
| 59 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.77063371 |
| 60 | axon extension involved in axon guidance (GO:0048846) | 2.77010016 |
| 61 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.77010016 |
| 62 | negative chemotaxis (GO:0050919) | 2.76881874 |
| 63 | regulation of synaptic plasticity (GO:0048167) | 2.76159368 |
| 64 | long-term memory (GO:0007616) | 2.74307962 |
| 65 | auditory behavior (GO:0031223) | 2.74207790 |
| 66 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.73096797 |
| 67 | cerebellar Purkinje cell layer development (GO:0021680) | 2.72696871 |
| 68 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.72027768 |
| 69 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.71602600 |
| 70 | dendrite morphogenesis (GO:0048813) | 2.71411022 |
| 71 | positive regulation of synapse assembly (GO:0051965) | 2.70988513 |
| 72 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.69972083 |
| 73 | regulation of postsynaptic membrane potential (GO:0060078) | 2.69499596 |
| 74 | synaptic vesicle endocytosis (GO:0048488) | 2.69347159 |
| 75 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.66893023 |
| 76 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.66204737 |
| 77 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.65528853 |
| 78 | gamma-aminobutyric acid transport (GO:0015812) | 2.63699790 |
| 79 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.63699677 |
| 80 | cellular potassium ion homeostasis (GO:0030007) | 2.63582111 |
| 81 | protein maturation by protein folding (GO:0022417) | 2.63361232 |
| 82 | organelle transport along microtubule (GO:0072384) | 2.61957299 |
| 83 | presynaptic membrane organization (GO:0097090) | 2.61747442 |
| 84 | synapse assembly (GO:0007416) | 2.61745329 |
| 85 | positive regulation of membrane potential (GO:0045838) | 2.60895730 |
| 86 | negative regulation of protein localization to cell surface (GO:2000009) | 2.60594328 |
| 87 | cell communication by electrical coupling (GO:0010644) | 2.60004469 |
| 88 | regulation of neurotransmitter transport (GO:0051588) | 2.59961546 |
| 89 | establishment of mitochondrion localization (GO:0051654) | 2.59488492 |
| 90 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.59390401 |
| 91 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.57601090 |
| 92 | synaptic vesicle transport (GO:0048489) | 2.55849303 |
| 93 | establishment of synaptic vesicle localization (GO:0097480) | 2.55849303 |
| 94 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.54052214 |
| 95 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.53900660 |
| 96 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.53274137 |
| 97 | startle response (GO:0001964) | 2.50943139 |
| 98 | synapse organization (GO:0050808) | 2.50559919 |
| 99 | regulation of neurotransmitter levels (GO:0001505) | 2.49965589 |
| 100 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.49946065 |
| 101 | membrane depolarization (GO:0051899) | 2.49356559 |
| 102 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.48868524 |
| 103 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.48868524 |
| 104 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.48836156 |
| 105 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.47821956 |
| 106 | membrane assembly (GO:0071709) | 2.47802559 |
| 107 | cell migration in hindbrain (GO:0021535) | 2.47683829 |
| 108 | synaptic transmission (GO:0007268) | 2.46955048 |
| 109 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.46560742 |
| 110 | retinal ganglion cell axon guidance (GO:0031290) | 2.45293959 |
| 111 | establishment of vesicle localization (GO:0051650) | 2.45136504 |
| 112 | dendritic spine organization (GO:0097061) | 2.44202491 |
| 113 | neuron projection extension (GO:1990138) | 2.43551237 |
| 114 | positive regulation of neurotransmitter transport (GO:0051590) | 2.43417270 |
| 115 | neuromuscular process controlling posture (GO:0050884) | 2.43404386 |
| 116 | positive regulation of synaptic transmission (GO:0050806) | 2.42682348 |
| 117 | neuromuscular process controlling balance (GO:0050885) | 2.42201891 |
| 118 | nerve growth factor signaling pathway (GO:0038180) | 2.42198941 |
| 119 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.42101567 |
| 120 | regulation of synapse assembly (GO:0051963) | 2.41690814 |
| 121 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.40768150 |
| 122 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.40514610 |
| 123 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.40362644 |
| 124 | positive regulation of potassium ion transport (GO:0043268) | 2.40207303 |
| 125 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.39901452 |
| 126 | neuronal ion channel clustering (GO:0045161) | 2.38080798 |
| 127 | protein heterotrimerization (GO:0070208) | 2.35484037 |
| 128 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.34702766 |
| 129 | glycosphingolipid biosynthetic process (GO:0006688) | 2.34009815 |
| 130 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.31912689 |
| 131 | mating behavior (GO:0007617) | 2.25778491 |
| 132 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.24620822 |
| 133 | regulation of cell communication by electrical coupling (GO:0010649) | 2.21418046 |
| 134 | ganglion development (GO:0061548) | 2.19366858 |
| 135 | transmission of nerve impulse (GO:0019226) | 2.18652649 |
| 136 | sequestering of actin monomers (GO:0042989) | 2.17755124 |
| 137 | negative regulation of axon extension (GO:0030517) | 2.17683019 |
| 138 | neuromuscular synaptic transmission (GO:0007274) | 2.15590267 |
| 139 | establishment of nucleus localization (GO:0040023) | 2.14593280 |
| 140 | negative regulation of neurotransmitter transport (GO:0051589) | 2.12783498 |
| 141 | hippocampus development (GO:0021766) | 2.12195881 |
| 142 | collagen fibril organization (GO:0030199) | 2.12065571 |
| 143 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.11561277 |
| 144 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.11108521 |
| 145 | cell communication involved in cardiac conduction (GO:0086065) | 2.10864936 |
| 146 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.10719867 |
| 147 | response to auditory stimulus (GO:0010996) | 2.10719516 |
| 148 | central nervous system neuron axonogenesis (GO:0021955) | 2.10272102 |
| 149 | regulation of axon extension (GO:0030516) | 2.09871157 |
| 150 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.09833069 |
| 151 | positive regulation of axon extension (GO:0045773) | 2.09190984 |
| 152 | cardiac ventricle formation (GO:0003211) | 2.09022235 |
| 153 | limb bud formation (GO:0060174) | 2.08425469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.82271990 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.75862409 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12609817 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10917442 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.92235148 |
| 6 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.73523756 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.68589293 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.63831924 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.63831924 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63501958 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.57072737 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.53406858 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47370640 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.46965851 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.45292597 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.40316666 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.19093985 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.10021005 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09545422 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07805909 |
| 21 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.97152101 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97012096 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91952289 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.86758697 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.83028615 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.81505335 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79742856 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77202178 |
| 29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74204610 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72366293 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71289592 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.69464667 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.66251193 |
| 34 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.63433134 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.61993437 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61978246 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59913636 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58858192 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.58391102 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52631351 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.47087350 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46507889 |
| 43 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46284943 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45540292 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43862942 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43210654 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41696776 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36815842 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36357573 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36240451 |
| 51 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35056922 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34252082 |
| 53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34206814 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33973844 |
| 55 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.30892830 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30558758 |
| 57 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.30124548 |
| 58 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28323972 |
| 59 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.28234826 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.26853084 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24660187 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23994982 |
| 63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23101685 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22610712 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21498589 |
| 66 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20879327 |
| 67 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20481908 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20010909 |
| 69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19878617 |
| 70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19361829 |
| 71 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.19097708 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18378827 |
| 73 | AR_19668381_ChIP-Seq_PC3_Human | 1.17543746 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16580257 |
| 75 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15777688 |
| 76 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15733611 |
| 77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15555745 |
| 78 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14326817 |
| 79 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13952006 |
| 80 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13605139 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13037309 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12440029 |
| 83 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.12000519 |
| 84 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11695108 |
| 85 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10356785 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08850039 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08850039 |
| 88 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08408578 |
| 89 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.05938237 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05669214 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05600772 |
| 92 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04625570 |
| 93 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03039143 |
| 94 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02698922 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02444784 |
| 96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01889522 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01648291 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01206576 |
| 99 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01201804 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01132699 |
| 101 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.00299348 |
| 102 | JUN_21703547_ChIP-Seq_K562_Human | 0.99535472 |
| 103 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.99400559 |
| 104 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98623050 |
| 105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98486635 |
| 106 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98440801 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97955757 |
| 108 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.97479394 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96956535 |
| 110 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96805813 |
| 111 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96797376 |
| 112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96020848 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95567460 |
| 114 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94966803 |
| 115 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94737405 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94670882 |
| 117 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92616092 |
| 118 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92067940 |
| 119 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90027043 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89881198 |
| 121 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88820060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.65046117 |
| 2 | MP0003880_abnormal_central_pattern | 3.64742570 |
| 3 | MP0004270_analgesia | 3.29998451 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.24554498 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 2.89710901 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.79226802 |
| 7 | MP0003122_maternal_imprinting | 2.69532428 |
| 8 | MP0009745_abnormal_behavioral_response | 2.63296206 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.56990334 |
| 10 | MP0000013_abnormal_adipose_tissue | 2.55639747 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.54857391 |
| 12 | MP0002064_seizures | 2.53198411 |
| 13 | MP0002736_abnormal_nociception_after | 2.45886039 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.42740271 |
| 15 | MP0009046_muscle_twitch | 2.35853360 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.25970807 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.23296922 |
| 18 | MP0002272_abnormal_nervous_system | 2.22742383 |
| 19 | MP0002733_abnormal_thermal_nociception | 1.99682750 |
| 20 | MP0010386_abnormal_urinary_bladder | 1.95092388 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.89861355 |
| 22 | MP0001970_abnormal_pain_threshold | 1.89246148 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.85198342 |
| 24 | MP0001501_abnormal_sleep_pattern | 1.80113629 |
| 25 | MP0001486_abnormal_startle_reflex | 1.78680694 |
| 26 | MP0002184_abnormal_innervation | 1.77584241 |
| 27 | MP0004858_abnormal_nervous_system | 1.72419668 |
| 28 | MP0005187_abnormal_penis_morphology | 1.70720854 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.67191283 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.61207775 |
| 31 | MP0001879_abnormal_lymphatic_vessel | 1.58738173 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.56943849 |
| 33 | MP0000751_myopathy | 1.56314870 |
| 34 | MP0001440_abnormal_grooming_behavior | 1.54557071 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.53067913 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.52304244 |
| 37 | MP0004084_abnormal_cardiac_muscle | 1.50389115 |
| 38 | MP0000778_abnormal_nervous_system | 1.50205009 |
| 39 | MP0006054_spinal_hemorrhage | 1.47492356 |
| 40 | MP0002102_abnormal_ear_morphology | 1.46880809 |
| 41 | MP0000955_abnormal_spinal_cord | 1.45749393 |
| 42 | MP0002822_catalepsy | 1.42775947 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.39238296 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.38388285 |
| 45 | MP0008569_lethality_at_weaning | 1.37693507 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.36950365 |
| 47 | MP0008438_abnormal_cutaneous_collagen | 1.35605091 |
| 48 | MP0001958_emphysema | 1.35454885 |
| 49 | MP0005394_taste/olfaction_phenotype | 1.35444067 |
| 50 | MP0005499_abnormal_olfactory_system | 1.35444067 |
| 51 | MP0003787_abnormal_imprinting | 1.35218206 |
| 52 | MP0003329_amyloid_beta_deposits | 1.32909492 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.32147238 |
| 54 | MP0003879_abnormal_hair_cell | 1.32044337 |
| 55 | MP0003279_aneurysm | 1.29676161 |
| 56 | MP0003283_abnormal_digestive_organ | 1.28716379 |
| 57 | MP0002751_abnormal_autonomic_nervous | 1.25632299 |
| 58 | MP0001299_abnormal_eye_distance/ | 1.25272860 |
| 59 | MP0004924_abnormal_behavior | 1.24469943 |
| 60 | MP0005386_behavior/neurological_phenoty | 1.24469943 |
| 61 | MP0005503_abnormal_tendon_morphology | 1.21159480 |
| 62 | MP0002295_abnormal_pulmonary_circulatio | 1.21048653 |
| 63 | MP0002882_abnormal_neuron_morphology | 1.20408323 |
| 64 | MP0008789_abnormal_olfactory_epithelium | 1.19837127 |
| 65 | MP0005171_absent_coat_pigmentation | 1.13149495 |
| 66 | MP0002066_abnormal_motor_capabilities/c | 1.12088099 |
| 67 | MP0004233_abnormal_muscle_weight | 1.10567058 |
| 68 | MP0001188_hyperpigmentation | 1.10212144 |
| 69 | MP0004085_abnormal_heartbeat | 1.09466142 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.08518269 |
| 71 | MP0001984_abnormal_olfaction | 1.05579228 |
| 72 | MP0003633_abnormal_nervous_system | 1.04844196 |
| 73 | MP0002653_abnormal_ependyma_morphology | 1.04437242 |
| 74 | MP0004043_abnormal_pH_regulation | 1.03299241 |
| 75 | MP0005248_abnormal_Harderian_gland | 1.03145736 |
| 76 | MP0003942_abnormal_urinary_system | 1.02183760 |
| 77 | MP0005257_abnormal_intraocular_pressure | 0.99335852 |
| 78 | MP0004215_abnormal_myocardial_fiber | 0.97798895 |
| 79 | MP0001944_abnormal_pancreas_morphology | 0.94182542 |
| 80 | MP0009384_cardiac_valve_regurgitation | 0.94060929 |
| 81 | MP0000003_abnormal_adipose_tissue | 0.92254775 |
| 82 | MP0001542_abnormal_bone_strength | 0.91253214 |
| 83 | MP0000049_abnormal_middle_ear | 0.90282437 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.89877436 |
| 85 | MP0003634_abnormal_glial_cell | 0.88786857 |
| 86 | MP0005379_endocrine/exocrine_gland_phen | 0.88744976 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.88339535 |
| 88 | MP0008775_abnormal_heart_ventricle | 0.88126653 |
| 89 | MP0002752_abnormal_somatic_nervous | 0.86218911 |
| 90 | MP0001177_atelectasis | 0.85905463 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 0.85445499 |
| 92 | MP0002233_abnormal_nose_morphology | 0.84269220 |
| 93 | MP0001905_abnormal_dopamine_level | 0.84118831 |
| 94 | MP0003121_genomic_imprinting | 0.83378335 |
| 95 | MP0003137_abnormal_impulse_conducting | 0.83106594 |
| 96 | MP0004142_abnormal_muscle_tone | 0.82982282 |
| 97 | MP0001529_abnormal_vocalization | 0.82793702 |
| 98 | MP0002896_abnormal_bone_mineralization | 0.82376040 |
| 99 | MP0003631_nervous_system_phenotype | 0.81761085 |
| 100 | MP0005623_abnormal_meninges_morphology | 0.81649483 |
| 101 | MP0008961_abnormal_basal_metabolism | 0.81013190 |
| 102 | MP0002152_abnormal_brain_morphology | 0.80228061 |
| 103 | MP0005275_abnormal_skin_tensile | 0.79854752 |
| 104 | MP0004036_abnormal_muscle_relaxation | 0.78722539 |
| 105 | MP0004885_abnormal_endolymph | 0.78264520 |
| 106 | MP0001664_abnormal_digestion | 0.78065580 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 0.77845944 |
| 108 | MP0000026_abnormal_inner_ear | 0.77836674 |
| 109 | MP0003755_abnormal_palate_morphology | 0.77001197 |
| 110 | MP0009250_abnormal_appendicular_skeleto | 0.76387786 |
| 111 | MP0002229_neurodegeneration | 0.74141974 |
| 112 | MP0002069_abnormal_eating/drinking_beha | 0.74011965 |
| 113 | MP0005508_abnormal_skeleton_morphology | 0.73672521 |
| 114 | MP0005253_abnormal_eye_physiology | 0.72905052 |
| 115 | MP0005535_abnormal_body_temperature | 0.70297902 |
| 116 | MP0002876_abnormal_thyroid_physiology | 0.70132402 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.69927638 |
| 118 | MP0001986_abnormal_taste_sensitivity | 0.69878870 |
| 119 | MP0000749_muscle_degeneration | 0.69722332 |
| 120 | MP0002108_abnormal_muscle_morphology | 0.69383645 |
| 121 | MP0002090_abnormal_vision | 0.69347988 |
| 122 | MP0004484_altered_response_of | 0.66614648 |
| 123 | MP0000534_abnormal_ureter_morphology | 0.66215583 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.65895460 |
| 125 | MP0002972_abnormal_cardiac_muscle | 0.64287571 |
| 126 | MP0001963_abnormal_hearing_physiology | 0.63705428 |
| 127 | MP0001943_abnormal_respiration | 0.63002050 |
| 128 | MP0003385_abnormal_body_wall | 0.62966856 |
| 129 | MP0005551_abnormal_eye_electrophysiolog | 0.62833412 |
| 130 | MP0004272_abnormal_basement_membrane | 0.62544371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.49084834 |
| 2 | Myokymia (HP:0002411) | 4.51970494 |
| 3 | Atonic seizures (HP:0010819) | 4.36388341 |
| 4 | Focal seizures (HP:0007359) | 4.16552108 |
| 5 | Visual hallucinations (HP:0002367) | 4.11313918 |
| 6 | Epileptic encephalopathy (HP:0200134) | 3.65646605 |
| 7 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.48618709 |
| 8 | Febrile seizures (HP:0002373) | 3.44971107 |
| 9 | Absence seizures (HP:0002121) | 3.42849587 |
| 10 | Pheochromocytoma (HP:0002666) | 3.27599819 |
| 11 | Action tremor (HP:0002345) | 3.10761538 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.09714012 |
| 13 | Premature rupture of membranes (HP:0001788) | 3.08519897 |
| 14 | Polyphagia (HP:0002591) | 3.04563189 |
| 15 | Dialeptic seizures (HP:0011146) | 3.02190318 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 2.96626716 |
| 17 | Neuroendocrine neoplasm (HP:0100634) | 2.96266463 |
| 18 | Agitation (HP:0000713) | 2.89809805 |
| 19 | Vascular tortuosity (HP:0004948) | 2.85964604 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 2.74483946 |
| 21 | Depression (HP:0000716) | 2.69019235 |
| 22 | Arterial tortuosity (HP:0005116) | 2.68891639 |
| 23 | Anxiety (HP:0000739) | 2.67593175 |
| 24 | Hypoventilation (HP:0002791) | 2.60095733 |
| 25 | Papilledema (HP:0001085) | 2.60063277 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 2.59669378 |
| 27 | Ankle clonus (HP:0011448) | 2.58207843 |
| 28 | Truncal ataxia (HP:0002078) | 2.57681436 |
| 29 | Aortic dissection (HP:0002647) | 2.54203504 |
| 30 | Failure to thrive in infancy (HP:0001531) | 2.50075062 |
| 31 | EEG with generalized epileptiform discharges (HP:0011198) | 2.46454250 |
| 32 | Hyperventilation (HP:0002883) | 2.45324022 |
| 33 | Congenital primary aphakia (HP:0007707) | 2.43353600 |
| 34 | Amblyopia (HP:0000646) | 2.39375505 |
| 35 | Neonatal short-limb short stature (HP:0008921) | 2.36735469 |
| 36 | Soft skin (HP:0000977) | 2.35953455 |
| 37 | Nephrogenic diabetes insipidus (HP:0009806) | 2.34470657 |
| 38 | Hypsarrhythmia (HP:0002521) | 2.34090269 |
| 39 | Cortical dysplasia (HP:0002539) | 2.30399835 |
| 40 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.29101570 |
| 41 | Bladder diverticulum (HP:0000015) | 2.27628442 |
| 42 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.22790386 |
| 43 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.22790386 |
| 44 | Excessive salivation (HP:0003781) | 2.20888683 |
| 45 | Drooling (HP:0002307) | 2.20888683 |
| 46 | Limb dystonia (HP:0002451) | 2.20836606 |
| 47 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.19245672 |
| 48 | Medial flaring of the eyebrow (HP:0010747) | 2.18722669 |
| 49 | Buphthalmos (HP:0000557) | 2.18574820 |
| 50 | Poor eye contact (HP:0000817) | 2.17566434 |
| 51 | Abnormality of dentin (HP:0010299) | 2.17140347 |
| 52 | Broad-based gait (HP:0002136) | 2.15550193 |
| 53 | Genital tract atresia (HP:0001827) | 2.13533217 |
| 54 | Insidious onset (HP:0003587) | 2.12714190 |
| 55 | Termporal pattern (HP:0011008) | 2.12714190 |
| 56 | Limb-girdle muscle weakness (HP:0003325) | 2.12306176 |
| 57 | Limb-girdle muscle atrophy (HP:0003797) | 2.11575514 |
| 58 | Atrophic scars (HP:0001075) | 2.10534744 |
| 59 | Papillary thyroid carcinoma (HP:0002895) | 2.10304584 |
| 60 | Torticollis (HP:0000473) | 2.09740118 |
| 61 | Menstrual irregularities (HP:0000858) | 2.09410501 |
| 62 | Vaginal atresia (HP:0000148) | 2.08722764 |
| 63 | Hypothermia (HP:0002045) | 2.08016722 |
| 64 | Abnormality of the ischium (HP:0003174) | 2.07533707 |
| 65 | Abnormality of the lower motor neuron (HP:0002366) | 2.06929706 |
| 66 | Left ventricular hypertrophy (HP:0001712) | 2.06708686 |
| 67 | Exercise-induced muscle cramps (HP:0003710) | 2.05555716 |
| 68 | Hammertoe (HP:0001765) | 2.05097186 |
| 69 | Infantile muscular hypotonia (HP:0008947) | 2.04397202 |
| 70 | Type 1 muscle fiber predominance (HP:0003803) | 2.04011947 |
| 71 | Abnormal eating behavior (HP:0100738) | 2.03777788 |
| 72 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.03322958 |
| 73 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.03081053 |
| 74 | Impaired pain sensation (HP:0007328) | 2.01540206 |
| 75 | Abnormality of pain sensation (HP:0010832) | 2.01540206 |
| 76 | Prolonged QT interval (HP:0001657) | 2.01454103 |
| 77 | Megalencephaly (HP:0001355) | 1.98082401 |
| 78 | Resting tremor (HP:0002322) | 1.97449552 |
| 79 | Abnormal social behavior (HP:0012433) | 1.97029095 |
| 80 | Impaired social interactions (HP:0000735) | 1.97029095 |
| 81 | Progressive inability to walk (HP:0002505) | 1.95672105 |
| 82 | Neoplasm of the heart (HP:0100544) | 1.95381853 |
| 83 | Morphological abnormality of the middle ear (HP:0008609) | 1.93015099 |
| 84 | Aortic aneurysm (HP:0004942) | 1.92836284 |
| 85 | Thyroid carcinoma (HP:0002890) | 1.92290122 |
| 86 | Follicular hyperkeratosis (HP:0007502) | 1.91692390 |
| 87 | Focal dystonia (HP:0004373) | 1.91283981 |
| 88 | Postural tremor (HP:0002174) | 1.90955342 |
| 89 | Scanning speech (HP:0002168) | 1.90775080 |
| 90 | Hemiparesis (HP:0001269) | 1.90191525 |
| 91 | Pachygyria (HP:0001302) | 1.89656901 |
| 92 | Steppage gait (HP:0003376) | 1.88127995 |
| 93 | Congenital glaucoma (HP:0001087) | 1.87796780 |
| 94 | Split foot (HP:0001839) | 1.87691302 |
| 95 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.85033060 |
| 96 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84708229 |
| 97 | Increased corneal curvature (HP:0100692) | 1.84632621 |
| 98 | Keratoconus (HP:0000563) | 1.84632621 |
| 99 | Specific learning disability (HP:0001328) | 1.83365158 |
| 100 | Hypercortisolism (HP:0001578) | 1.82375607 |
| 101 | Wide anterior fontanel (HP:0000260) | 1.81807714 |
| 102 | Heterochromia iridis (HP:0001100) | 1.81392965 |
| 103 | Abnormal hair whorl (HP:0010721) | 1.80708441 |
| 104 | Hyperthyroidism (HP:0000836) | 1.80020500 |
| 105 | Bradycardia (HP:0001662) | 1.79711249 |
| 106 | Spinal canal stenosis (HP:0003416) | 1.79533427 |
| 107 | Dysdiadochokinesis (HP:0002075) | 1.78759065 |
| 108 | Calf muscle hypertrophy (HP:0008981) | 1.77518384 |
| 109 | Gaze-evoked nystagmus (HP:0000640) | 1.75837890 |
| 110 | Cerebral inclusion bodies (HP:0100314) | 1.75242509 |
| 111 | Abnormality of the corticospinal tract (HP:0002492) | 1.74638484 |
| 112 | Urinary urgency (HP:0000012) | 1.74197536 |
| 113 | Dysmetria (HP:0001310) | 1.72548712 |
| 114 | Craniofacial dystonia (HP:0012179) | 1.72504077 |
| 115 | Gait imbalance (HP:0002141) | 1.72358197 |
| 116 | Mitral stenosis (HP:0001718) | 1.72105368 |
| 117 | Delayed gross motor development (HP:0002194) | 1.71908326 |
| 118 | Bowel diverticulosis (HP:0005222) | 1.71667792 |
| 119 | Spinal rigidity (HP:0003306) | 1.71306458 |
| 120 | Fetal akinesia sequence (HP:0001989) | 1.70510713 |
| 121 | Myotonia (HP:0002486) | 1.70392957 |
| 122 | Sudden death (HP:0001699) | 1.70151096 |
| 123 | Arthropathy (HP:0003040) | 1.69493620 |
| 124 | Vitreoretinal degeneration (HP:0000655) | 1.69006322 |
| 125 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.68978372 |
| 126 | Narrow nasal bridge (HP:0000446) | 1.68310232 |
| 127 | Lower limb asymmetry (HP:0100559) | 1.67990487 |
| 128 | Hypoplasia of the iris (HP:0007676) | 1.67859204 |
| 129 | Ulnar claw (HP:0001178) | 1.67831836 |
| 130 | Absent speech (HP:0001344) | 1.67546085 |
| 131 | Psychosis (HP:0000709) | 1.67438610 |
| 132 | Atrial fibrillation (HP:0005110) | 1.66528334 |
| 133 | Decreased circulating renin level (HP:0003351) | 1.66348495 |
| 134 | Hypoplasia of the brainstem (HP:0002365) | 1.66308025 |
| 135 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.66308025 |
| 136 | Overgrowth (HP:0001548) | 1.66170972 |
| 137 | Macroorchidism (HP:0000053) | 1.66143333 |
| 138 | Hypoplastic ischia (HP:0003175) | 1.65699799 |
| 139 | Akinesia (HP:0002304) | 1.65673653 |
| 140 | Pulmonary artery stenosis (HP:0004415) | 1.64870200 |
| 141 | Exotropia (HP:0000577) | 1.64427283 |
| 142 | Shoulder girdle muscle weakness (HP:0003547) | 1.63984839 |
| 143 | Protrusio acetabuli (HP:0003179) | 1.63200996 |
| 144 | Short foot (HP:0001773) | 1.62931137 |
| 145 | Distal arthrogryposis (HP:0005684) | 1.62818563 |
| 146 | Type II lissencephaly (HP:0007260) | 1.62179643 |
| 147 | Spastic gait (HP:0002064) | 1.60814155 |
| 148 | Lower limb muscle weakness (HP:0007340) | 1.60734679 |
| 149 | Neurofibrillary tangles (HP:0002185) | 1.60480437 |
| 150 | Abnormality of the calf musculature (HP:0001430) | 1.60462660 |
| 151 | Diplopia (HP:0000651) | 1.60403369 |
| 152 | Abnormality of binocular vision (HP:0011514) | 1.60403369 |
| 153 | Gait ataxia (HP:0002066) | 1.59875008 |
| 154 | Impaired smooth pursuit (HP:0007772) | 1.59554462 |
| 155 | Abnormal EKG (HP:0003115) | 1.58791697 |
| 156 | Retinal dysplasia (HP:0007973) | 1.58309008 |
| 157 | Stereotypic behavior (HP:0000733) | 1.57494952 |
| 158 | Exercise-induced myalgia (HP:0003738) | 1.56409522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.27734282 |
| 2 | EPHA4 | 3.12554325 |
| 3 | MAP3K9 | 2.75605458 |
| 4 | MAP3K4 | 2.68364386 |
| 5 | MINK1 | 2.65551648 |
| 6 | CASK | 2.54723002 |
| 7 | MAP2K7 | 2.53471667 |
| 8 | NTRK1 | 2.36598223 |
| 9 | PINK1 | 2.17179304 |
| 10 | MARK1 | 2.13790693 |
| 11 | PLK2 | 2.02594298 |
| 12 | MAP3K12 | 1.99012065 |
| 13 | TRIM28 | 1.94887960 |
| 14 | EPHB2 | 1.94591774 |
| 15 | PRKD3 | 1.92869616 |
| 16 | MAP4K2 | 1.83251813 |
| 17 | MAP3K2 | 1.79572856 |
| 18 | RIPK4 | 1.78821450 |
| 19 | MAP2K4 | 1.73035400 |
| 20 | KSR2 | 1.68103882 |
| 21 | FRK | 1.67778925 |
| 22 | CAMKK2 | 1.66564060 |
| 23 | DAPK2 | 1.64068201 |
| 24 | UHMK1 | 1.54320649 |
| 25 | PAK6 | 1.53954992 |
| 26 | INSRR | 1.51415499 |
| 27 | FER | 1.49230485 |
| 28 | CAMKK1 | 1.42679399 |
| 29 | DYRK2 | 1.38948976 |
| 30 | CDK5 | 1.38336372 |
| 31 | GRK5 | 1.34590622 |
| 32 | CSNK1G3 | 1.31964497 |
| 33 | ARAF | 1.28251474 |
| 34 | NTRK2 | 1.27673778 |
| 35 | PAK3 | 1.26451626 |
| 36 | LIMK1 | 1.26109632 |
| 37 | CSNK1A1L | 1.23859590 |
| 38 | MAPK13 | 1.22776404 |
| 39 | CDK19 | 1.19352247 |
| 40 | SCYL2 | 1.18715216 |
| 41 | CSNK1G1 | 1.13621326 |
| 42 | RET | 1.13477813 |
| 43 | WNK3 | 1.13406813 |
| 44 | CAMK2A | 1.10718292 |
| 45 | FES | 1.10441045 |
| 46 | PDGFRA | 1.10019872 |
| 47 | PTK2B | 1.08199553 |
| 48 | DAPK1 | 1.08198134 |
| 49 | PRKCG | 1.07967560 |
| 50 | KSR1 | 1.06915531 |
| 51 | OBSCN | 1.05426809 |
| 52 | SGK494 | 1.00342920 |
| 53 | SGK223 | 1.00342920 |
| 54 | PRKCE | 0.98451828 |
| 55 | STK38L | 0.98441661 |
| 56 | PRKCH | 0.97761429 |
| 57 | PRPF4B | 0.97468549 |
| 58 | TIE1 | 0.96918740 |
| 59 | WNK4 | 0.96589763 |
| 60 | CAMK2B | 0.95991407 |
| 61 | CDK14 | 0.94508830 |
| 62 | DYRK1B | 0.88657417 |
| 63 | EPHA3 | 0.88623332 |
| 64 | DDR2 | 0.87429314 |
| 65 | MAP3K1 | 0.83712848 |
| 66 | SIK2 | 0.83478396 |
| 67 | PIK3CA | 0.81946113 |
| 68 | ERBB3 | 0.81301874 |
| 69 | SGK2 | 0.78161961 |
| 70 | CAMK2D | 0.77978811 |
| 71 | PHKG2 | 0.77585542 |
| 72 | PHKG1 | 0.77585542 |
| 73 | CDK18 | 0.77397839 |
| 74 | NEK9 | 0.77230210 |
| 75 | WNK1 | 0.76316266 |
| 76 | CDK15 | 0.74343670 |
| 77 | PNCK | 0.71474347 |
| 78 | MAP2K1 | 0.70754158 |
| 79 | BMPR2 | 0.70356711 |
| 80 | TNIK | 0.68888424 |
| 81 | MAP3K13 | 0.68859311 |
| 82 | NME1 | 0.68274891 |
| 83 | CAMK1 | 0.66095078 |
| 84 | DYRK1A | 0.65683573 |
| 85 | CDC42BPA | 0.65035926 |
| 86 | ADRBK2 | 0.64803973 |
| 87 | SIK3 | 0.63913978 |
| 88 | GRK7 | 0.62148583 |
| 89 | PKN1 | 0.61813369 |
| 90 | DYRK3 | 0.61719807 |
| 91 | LATS2 | 0.61528643 |
| 92 | HIPK2 | 0.61500864 |
| 93 | ADRBK1 | 0.61202665 |
| 94 | MYLK | 0.60964472 |
| 95 | CDK11A | 0.59152113 |
| 96 | PAK2 | 0.58517252 |
| 97 | GRK1 | 0.58300341 |
| 98 | FGFR2 | 0.58041398 |
| 99 | YES1 | 0.58007416 |
| 100 | OXSR1 | 0.55739647 |
| 101 | STK38 | 0.54084059 |
| 102 | LMTK2 | 0.53486689 |
| 103 | EPHB1 | 0.53439989 |
| 104 | SGK1 | 0.53150996 |
| 105 | AKT3 | 0.52910573 |
| 106 | CSNK1G2 | 0.51986216 |
| 107 | SGK3 | 0.51983012 |
| 108 | TRIB3 | 0.50593320 |
| 109 | CAMK2G | 0.50346223 |
| 110 | TESK1 | 0.49330550 |
| 111 | PKN2 | 0.48955183 |
| 112 | MAPK15 | 0.48639578 |
| 113 | LATS1 | 0.47221569 |
| 114 | FYN | 0.46943298 |
| 115 | STK39 | 0.46515040 |
| 116 | PRKD1 | 0.46286889 |
| 117 | RPS6KA2 | 0.46162945 |
| 118 | MAP3K5 | 0.46095610 |
| 119 | PDGFRB | 0.45125830 |
| 120 | BCKDK | 0.44486935 |
| 121 | PTK2 | 0.44164649 |
| 122 | ROCK2 | 0.43785972 |
| 123 | PRKCZ | 0.43622185 |
| 124 | NEK6 | 0.43392448 |
| 125 | PDPK1 | 0.42857780 |
| 126 | MOS | 0.42486801 |
| 127 | ROCK1 | 0.41896490 |
| 128 | TYRO3 | 0.41847228 |
| 129 | PRKG1 | 0.41043329 |
| 130 | ERBB2 | 0.40411615 |
| 131 | CSNK1D | 0.40197142 |
| 132 | BCR | 0.39940827 |
| 133 | PDK1 | 0.39204163 |
| 134 | RPS6KA3 | 0.39196650 |
| 135 | RPS6KA4 | 0.38688259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.01029764 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.78155396 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.31154338 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 2.29408987 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.28687679 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.28553989 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.22885361 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.22003864 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.12914654 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.03229430 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.98732037 |
| 12 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.97928301 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.96356462 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95464372 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.93215066 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.92446875 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.71627107 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71172602 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66914106 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.64519560 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.63835352 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.60424020 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.59852302 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.58161032 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.53965872 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.53231314 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51488520 |
| 28 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.40650951 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38411580 |
| 30 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.38279079 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33394088 |
| 32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.33358091 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.28071609 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25436449 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.23709235 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18906240 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18502219 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.16674848 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15309643 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13725475 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12888724 |
| 42 | Protein export_Homo sapiens_hsa03060 | 1.11390965 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11231564 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09636635 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08524928 |
| 46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07461678 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04854153 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.04549174 |
| 49 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03529121 |
| 50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98352390 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.97784437 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 0.95815659 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94669544 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94397763 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92991312 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92156224 |
| 57 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.91496182 |
| 58 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.91440581 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.89456645 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.89222960 |
| 61 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88631555 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88516409 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86842891 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86244824 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83485902 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83333816 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83058434 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81812620 |
| 69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.77795294 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76534900 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.76463703 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75604881 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.75158174 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74889513 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73428222 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72981801 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71948959 |
| 78 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69975271 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68950899 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67245757 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.66579289 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66489847 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65986534 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.64776560 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62979870 |
| 86 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.59858447 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58795460 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58456988 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.58225300 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58020029 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.57484453 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57234088 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56817323 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56672872 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55970703 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55641531 |
| 97 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54929730 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54140374 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53881119 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53861883 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53731807 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53546206 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51422642 |
| 104 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.50834826 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50614360 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50307917 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50006326 |
| 108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49990790 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.49623711 |
| 110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48529026 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47822806 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47478956 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47172209 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46997081 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.46397743 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45480543 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45329201 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.45291801 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44845217 |
| 120 | Melanoma_Homo sapiens_hsa05218 | 0.42702480 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41282391 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.40794977 |
| 123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40614374 |
| 124 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40175657 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40162217 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.38102057 |

